BASF to Invest in Novartis's Austrian Facility
03 Mayo 2021 - 8:59AM
Noticias Dow Jones
By Mauro Orru
BASF SE said Monday that it has agreed with Sandoz GmbH, a
subsidiary of Swiss pharmaceutical major Novartis AG, to make
investments at the company's Kundl/Schaftenau Campus in
Austria.
The German chemicals company didn't disclose financial details
for the agreement signed on April 26, which is aimed at bolstering
BASF's production footprint for enzymes and biotechnology
products.
The start of production is planned for 2024, BASF said.
Write to Mauro Orru at mauro.orru@wsj.com; @MauroOrru94
(END) Dow Jones Newswires
May 03, 2021 09:44 ET (13:44 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
BASF (TG:BAS)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
BASF (TG:BAS)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024
